| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 01/25/2007 | US20070021473 Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof |
| 01/25/2007 | US20070021427 Novel tricyclic derivatives and their use |
| 01/25/2007 | US20070021394 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
| 01/25/2007 | US20070021354 Viricides; immunomoderator; mixture with other Aids drugs |
| 01/25/2007 | CA2615978A1 Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field |
| 01/24/2007 | EP1746111A1 Polymerisation catalyst system based on dioxime ligands |
| 01/24/2007 | EP1745009A1 Heteroaryl substituted cyclohexyl-1,4-diamine derivatives |
| 01/24/2007 | EP1744755A2 Compounds and compositions as cathepsin s inhibitors |
| 01/24/2007 | EP1334970B1 Novel ft-0554a substances and process for the preparation thereof |
| 01/24/2007 | CN1902188A Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/24/2007 | CN1900082A Medicinal compound for resisting platelet activating factor |
| 01/24/2007 | CN1900077A New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
| 01/24/2007 | CN1900072A Process for supersonically extracting usnic acid |
| 01/24/2007 | CN1900067A Tricyclic compounds, their production and use |
| 01/24/2007 | CN1296372C A method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives |
| 01/24/2007 | CN1296365C Imidazolinylmethyl aralkylsulfonamides |
| 01/23/2007 | US7166746 Fungicides for controlling and preventing an infestation of crop plants by phytopathogenic microorganisms; 2-hydroxy-N-[trans-2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-cyclohexyl]-2-phenyl-acetamide |
| 01/23/2007 | US7166730 Starting from a Corey aldehyde, i.e., 5-arylcarbonyloxycyclopenta[b]furan-2-one-4-carboxaldehyde; also crystalline 5-hydroxycyclopenta[b]furan-2-one and 2-ol derivatives 4-substituted with siloxyakyl groups as intermediates |
| 01/23/2007 | US7166729 Process for the preparation of 5-substituted isobenzofurans |
| 01/23/2007 | US7166727 Product of a porous silica that may contain Zr, Al and/or Ti and an organic compound of K, Cs and/or Rb, with a pore volume of at least 0.3 cubic centimeters per gram of catalyst attributable to pores having a diameter of 65-3200 Angstroms; reacting a butyrolactone (especially G-valerolactone) with CH2O |
| 01/23/2007 | US7166622 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome |
| 01/23/2007 | US7166601 A phenylamide derivatives for treating gastrointestinal reflux disorders, eating disorder obesity and irritable bowel disorder |
| 01/23/2007 | US7166592 Antiinflammatory agents |
| 01/23/2007 | US7166590 Antiischemic agents; cardiovascular disorders |
| 01/23/2007 | US7166588 Derivatives and analogs of galanthamine |
| 01/18/2007 | WO2007008501A1 Antidiabetic oxazolidinediones and thiazolidinediones |
| 01/18/2007 | WO2007007937A1 Tricyclic tetrahydrofuran derivatives and process for the preparation thereof |
| 01/18/2007 | WO2007007668A1 Therapeutic agent and treatment method for ameliorating uremia |
| 01/18/2007 | WO2007007646A1 Homogeneous asymmetric hydrogenation catalyst |
| 01/18/2007 | WO2007006734A1 New benzoheterocyclylethylbenzamide derivatives |
| 01/18/2007 | WO2007006532A1 New pyrocatechin derivatives |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015664 2,4,6-Phenyl substituted cyclic ketoenols |
| 01/18/2007 | US20070014822 2-[1-methyl-3-(2,6,6-trimethyl-1-cyclohexen-1-yl)allyl]-1,3-dioxolane; high stability, high strength, better lingering power; soaps, shower gels, shampoos, bath additives, skin creams, body lotions and deodorants, detergents; acetalization of 2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butenal |
| 01/18/2007 | DE102005031314A1 Verfahren zur Abtrennung von Maleinsäureanhydrid aus maleinsäureanhydridhaltigen Gemischen durch Strippung Process for the separation of maleic anhydride from maleic anhydride mixtures by stripping |
| 01/18/2007 | CA2618708A1 Therapeutic agent and treatment method for ameliorating uremia |
| 01/18/2007 | CA2614715A1 New pyrocatechin derivatives |
| 01/18/2007 | CA2613458A1 Compounds with activity at retinoic acid receptors |
| 01/18/2007 | CA2612765A1 Antidiabetic oxazolidinediones and thiazolidinediones |
| 01/17/2007 | EP1743635A2 Gibberellins for the promotion of ulcer healing |
| 01/17/2007 | EP1743170A2 Methods for detecting substances which bind to the amyloid precursor protein or beta amyloid fragments, and binding compounds |
| 01/17/2007 | EP1742931A1 Dibenzofuran derivatives, dibenzothiophene derivatives, and fluorene derivatives |
| 01/17/2007 | EP1742930A1 Pyrethroid pesticide |
| 01/17/2007 | EP1742929A1 Trisubstituted furans suitable for the preparation of fragrance compositions |
| 01/17/2007 | EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 01/17/2007 | EP1742914A1 Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 01/17/2007 | EP1742908A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/17/2007 | EP1742906A2 Non-linear optically active molecules, their synthesis, and use |
| 01/17/2007 | EP1482925B1 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl]-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy |
| 01/17/2007 | EP1401575B1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 01/17/2007 | CN1898227A Ornithine derivatives as prostaglandin e2 agonists or antagonists |
| 01/17/2007 | CN1898226A Process for the preparation of n-alkyl-2(hydroxy-4 benzoyl)-3 benzofurans and its intermediates thereof |
| 01/17/2007 | CN1898225A Novel alkoxylactones, alkoxylactames and alkoxythiolactames for controlling processes based on microbial interaction |
| 01/17/2007 | CN1898214A Dicationic triaryl analogs as anti-protozoan agents |
| 01/17/2007 | CN1898213A Heteroaroyl-substituted phenylalanineamides with herbicidal action |
| 01/17/2007 | CN1897931A Inhibitors of cathepsin s |
| 01/17/2007 | CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 01/17/2007 | CN1896070A 2- and 2,5-substituted phenylketo-enols |
| 01/17/2007 | CN1295217C New asymmetric diaryl-methylamine intermediates for the preparation of diarylmethylpiperazines derivatives |
| 01/17/2007 | CN1295200C 2-butyl-3-(4-[3-(dibutylamino) propoxy] benzoyl)-5-nitro-benzofuran hydrochloride and preparation thereof |
| 01/17/2007 | CN1295016C Catalyst-precursor for the production of maleic acid anhydride and method for the production thereof |
| 01/16/2007 | US7164033 Gas phase synthesis of methylene lactones using novel catalyst |
| 01/16/2007 | US7164032 Supercritical fluid phase synthesis of methylene lactones using novel catalyst field of invention |
| 01/16/2007 | US7163957 anti-psychotic; selectively interact with the dopaminergic receptors of the D2/D3 subtypes and the serotoninergic receptors of the 5-HT1A subtype at the level of which they behave as antagonists and agonists, respectively |
| 01/16/2007 | US7163827 Colorless and soluble in organic products, use for detecting petroleum fuels or solvents |
| 01/16/2007 | CA2221397C Process for the production of aromatic halogen-amino compounds |
| 01/11/2007 | WO2007004442A1 Process for production of substituted cyclopentanone |
| 01/11/2007 | WO2007003662A1 Method for start-up of oxidation catalysts |
| 01/11/2007 | WO2006063220A3 Preparation of 2,5-(hydr0xymethyl)furaldehyde (hmf) , derivatives thereof and levulinic acid from fructose as well as preparation of 2 , 5-bis- (hydroxymethyl) furan from 2 , 5- (hydroxymethyl) furaldehyde |
| 01/11/2007 | US20070010632 Antioxidant-functionalized polymers |
| 01/11/2007 | US20070010533 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 01/11/2007 | US20070010489 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
| 01/11/2007 | US20070010453 Prodrugs of GABA analogs, compositions and uses thereof |
| 01/11/2007 | DE102005031465A1 Verfahren zum Anfahren von Oxidationskatalysatoren Method for starting of oxidation catalysts |
| 01/11/2007 | CA2614226A1 High yield synthesis methods for producing organic salts of strontium |
| 01/10/2007 | EP1741706A1 11-methyl-13-tridecanolide, 12-methyl-14-tetradeca- nolide and 13-methyl-15-pentadecanolide, perfume compositions containing the same, and process for the production of compounds including the same |
| 01/10/2007 | EP1741705A1 Fluorinated cyclic structure-bearing silicon compounds and silicone resins, resist compositions using the same, and patterning process |
| 01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
| 01/10/2007 | EP1740568A2 Benzofuran and benzothiophene derivatives useful for the treatment of cardiovascular disease. |
| 01/10/2007 | EP1740565A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sufide derivatives |
| 01/10/2007 | EP1740564A2 Process for preparation of mycophenolic acid and ester derivatives thereof |
| 01/10/2007 | EP1740563A2 Mycophenolate mofetil impurity |
| 01/10/2007 | EP1740561A2 Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them |
| 01/10/2007 | EP1740559A1 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/10/2007 | EP1740535A1 Thio-substituted methanesulfinyl derivatives |
| 01/10/2007 | EP1740531A1 Indene derivatives and process for the preparation thereof |
| 01/10/2007 | EP1740522A2 Bisphenyl compounds useful as vitamin d sb 3 /sb receptor agonists |
| 01/10/2007 | EP1740225A2 Contrast agents for myocardial perfusion imaging |
| 01/10/2007 | CN1894256A Method for preparing spironolactone compounds |
| 01/10/2007 | CN1894233A Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2h-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them |
| 01/10/2007 | CN1894232A Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 01/10/2007 | CN1894231A Furan derivatives as ep4 receptor antagonists |
| 01/10/2007 | CN1894230A A process for the liquefaction of lignocellulosic material |
| 01/10/2007 | CN1894209A Prostaglandin synthesis |
| 01/10/2007 | CN1894206A N-substituted-N-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 01/10/2007 | CN1894195A Ether compounds and compositions for cholesterol management and related uses |
| 01/10/2007 | CN1893939A Composition for preventing and treating hepatoma |
| 01/10/2007 | CN1891698A Method forproducing carbamate |